A Phase 1, Multicenter, Open-Label Study Of Bms-986403 In Subjects With Relapsed And/Or Refractory Chronic Lymphocytic Leukemia (Cll) Or Small Lymphocytic Lymphoma (Sll) Read more
Long-Term Follow-Up Study For Participants Of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells Read more
An Open-label Phase 1 Study to Evaluate Pharmacokinetics, Safety, and Tolerability of SY-2101 in Adult Patients with Acute Promyelocytic Leukemia Read more
An Open-Label, Multicenter, Phase 1b/2 Study Of The Safety And Efficacy Of TL-895 Combined With KRT-232 In Subjects With Relapsed/Refractory (R/R) FLT3+ Acute Myeloid Leukemia (AML) Read more
Vyxeos Outpatient Induction Therapy Without Subsequent Planned Admission: A Multicenter Analysis Of Safety And Medical Resource Utilization Read more
